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1. Introduction {#sec1}
===============

Non-heme iron enzymes carry out critical oxidative transformations in biology.^[@ref1]^ These enzymes activate dioxygen, with the aid of a two-electron sacrificial reductant, to generate a highly reactive oxoiron(IV) species, which is proposed to be the active intermediate in the oxidation of a number of important biomolecules. Oxoiron(IV) intermediates have been elegantly trapped and characterized by the efforts of Krebs and Bollinger in a number of different enzymes,^[@ref2]^ the first of which was taurine dioxygenase (TauD) in 2003.^[@ref3],[@ref4]^ The enzymatic oxoiron(IV) intermediate, TauD-***J***, has an *S* = 2 ground spin state with an isomer shift of 0.30 mm/s. The high-spin state of TauD-***J*** has been rationalized by the presence of weak-field ligands, such as histidines and carboxylates, that support the Fe^IV^(O) center. Since 2003, oxoiron(IV) intermediates in two more classes of non-heme iron enzymes have been trapped and characterized, all of which demonstrate *S* = 2 ground states with isomer shifts in the range of 0.22--0.30 mm/s (Table [1](#tbl1){ref-type="other"}).^[@ref2],[@ref5]^

Also in 2003, we reported the first structurally characterized synthetic oxoiron(IV) complex, \[Fe^IV^(O)(TMC)(MeCN)\]^2+^.^[@ref6]^ However, unlike TauD-***J***, \[Fe^IV^(O)(TMC)(MeCN)\]^2+^ has an *S* = 1 ground spin state, and its Mossbauer parameters are notably different, with an isomer shift of 0.17 mm/s. In the years since, over 60 additional synthetic oxoiron(IV) species have been reported, with more than 90% of them characterized as having an *S* = 1 ground state.^[@ref5]^ The initial investigations of these new *S* = 1 oxoiron(IV) complexes were discussed in a 2007 Account by one of us.^[@ref7]^ At the time, the only reported *S* = 2 oxoiron(IV) complex was \[Fe^IV^(O)(OH~2~)~5~\]^2+^ (**1**) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), characterized by Bakac,^[@ref8]^ in which the oxoiron(IV) center is supported by weak-field aqua ligands. Complex **1** was found to be a powerful oxidant that can undergo fast hydrogen-atom transfer (HAT) reactions with a range of organic substrates.^[@ref9]^ While the isomer shift of 0.38(2) mm s^--1^ found for **1** made it a close spectroscopic analogue to TauD-***J***, its short half-life of 7 s at 25 °C and the aqueous medium have limited further studies. Since then, our group and others have attempted to address the discrepancy in electronic structure between enzymatic and synthetic oxoiron(IV) systems by synthesizing *S* = 2 oxoiron(IV) complexes supported by polydentate ligands. This Account focuses on synthetic strategies that may be employed to stabilize the *S* = 2 ground state, as illustrated by the high-spin oxoiron(IV) complexes in [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}.

![Structures of *S* = 2 oxoiron(IV) complexes **1** and **14**, based on DFT-derived coordinates from refs ([@ref8]) and ([@ref10]), and of **2** and **4**, based on crystallographic data from refs ([@ref11]) and ([@ref12]).](ar-2015-00244y_0001){#fig1}

From the d-orbital splitting diagram for a pseudo-octahedral metal--oxo center, first detailed by Ballhausen and Gray in 1962 and revisited recently by Winkler and Gray,^[@ref13]^ it can be seen that the energy gap between the d~*x*^2^--*y*^2^~ and d~*xy*~ orbitals competes with the spin-pairing energy to determine whether an *S* = 1 intermediate-spin state or an *S* = 2 high-spin state is formed ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, left). Therefore, the key to achieving an *S* = 2 spin state is to diminish the energy gap between the d~*xy*~ and d~*x*^2^--*y*^2^~ orbitals. There are a number of synthetic approaches to achieve this goal. In [section [2](#sec2){ref-type="other"}](#sec2){ref-type="other"} we describe the use of bulky tripodal ligands to enforce a trigonal-bipyramidal geometry about the oxoiron(IV) center, thereby making the d~*xy*~ and d~*x*^2^--*y*^2^~ orbitals degenerate ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, right) and allowing for an *S* = 2 ground state. In [sections [3](#sec3){ref-type="other"}](#sec3){ref-type="other"} and [4](#sec4){ref-type="other"}, we highlight different attempts to decrease the energy gap between the d*~xy~* and the d~*x*^2^--*y*^2^~ orbital in a pseudo-octahedral geometry, leading in some instances to stabilization of the *S* = 2 ground state.

![Splitting patterns for d orbitals associated with oxoiron(IV) complexes in (left) pseudo-octahedral and (right) trigonal-bipyramidal geometries.](ar-2015-00244y_0002){#fig2}

2. Trigonal-Bipyramidal *S* = 2 Oxoiron(IV) Complexes {#sec2}
=====================================================

The majority of reported synthetic oxoiron(IV) complexes have an *S* = 1 ground state, likely because of a combination of the relatively strong-field ligands employed, namely, tertiary amines and pyridines, and the six-coordinate pseudo-octahedral geometry these complexes adopt, leading to pairing of electrons in the lowest-lying d~*xy*~ orbital ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, left). In contrast, the geometry of enzymatic *S* = 2 oxoiron(IV) species is still under debate, with both trigonal-bipyramidal and pseudo-octahedral configurations being plausible. Theoretical calculations performed on TauD-***J*** by Neese supported the possibility of either geometry,^[@ref4]^ while the recent analysis of nuclear resonance vibrational spectroscopy data by Solomon favored a trigonal-bipyramidal geometry for the oxoiron(IV) intermediate in the halogenase SyrB2.^[@ref14]^

With this in mind, one synthetic strategy to diminish the energy gap between the d~*xy*~ and d~*x*^2^--*y*^2^~ orbitals is to move away from the six-coordinate pseudo-octahedral geometry adopted by the majority of oxoiron(IV) complexes and toward a *C*~3~-symmetric trigonal-bipyramidal geometry, where the d~*xy*~ and d~*x*^2^--*y*^2^~ orbitals become degenerate, guaranteeing population of four unpaired electrons and access to an *S* = 2 ground state ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}, right).

The first example of a trigonal-bipyramidal *S* = 2 oxoiron(IV) complex came from our group in 2009 when postdoctoral associate Jason England utilized the sterically bulky TMG~3~tren ligand to stabilize the oxoiron(IV) species \[Fe^IV^(O)(TMG~3~tren)\]^2+^ (**2**) ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}).^[@ref15]^ The benefits of the tripodal tetradentate ligand were twofold: first, the electron-richness of the imine donors helped stabilize the high-valent Fe^IV^ oxidation state; second, the steric bulk of the six dimethylamine end caps enforced the *C*~3~ symmetry while preventing formation of undesired (μ-oxo)diferric byproducts. Mössbauer spectroscopy of **2** revealed a quadrupole doublet with δ = 0.09 mm s^--1^ and Δ*E*~Q~ = −0.29 mm s^--1^. While the isomer shift of **2** was notably smaller than that of the enzymatic intermediate TauD-***J***, high-field Mössbauer experiments established **2** to have an *S* = 2 ground state ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}).

![Synthetic trigonal-bipyramidal *S* = 2 oxoiron(IV) complexes.](ar-2015-00244y_0003){#fig3}

###### Spectroscopic Signatures of Selected *S* = 1 and *S* = 2 Oxoiron(IV) Species

  complex                                                        *S*   near-IR bands (nm)   δ (mm/s)     Δ*E*~Q~ (mm/s)   *D* (cm^--1^)   ref(s)
  -------------------------------------------------------------- ----- -------------------- ------------ ---------------- --------------- ------------------------
  \[Fe^IV^(O)(TMC)(MeCN)\]^2+^                                   1     824                  0.17         1.24             27              ([@ref6]), ^[@ref59]^
  \[Fe^IV^(O)(N4Py)\]^2+^                                        1     695                  --0.04       0.93             22              ([@ref60])
  \[Fe^IV^(O)(OH~2~)~5~\]^2+^ (**1**)                            2                          0.38         0.33             9.7(7)          ([@ref8])
  \[Fe^IV^(O)(TMG~3~tren)\]^2+^ (**2**)                          2     825                  0.09         --0.29           5.0(5)          ([@ref15])
  \[Fe^IV^(O)(TMG~2~dien)(X)\]^+/2+^ (**3-X**)                                                                                            
  X = MeCN                                                       2     724, 805             0.08         0.58             4.5(5)          ([@ref17])
  X = Cl                                                         2     745, 803             0.08         0.41             4.0(5)           
  X = N~3~                                                       2     827                  0.12         --0.30           4.6(5)           
  \[Fe^IV^(O)(H~3~buea)\]^1--^ (**4**)                           2     808                  0.02         0.43             4.0(5)          ([@ref12])
  \[Fe^IV^(O)(tpa^Ph^)\]^1--^ (**5**)                            2     ∼900                 0.09         0.51             4.3             ([@ref20])
  \[Fe^IV^(O)(TPA\*)(MeCN)\]^2+^ (**11**)                        1                          0.01         0.95                             ([@ref61])
  \[(HO)(L) Fe^IV^--O--Fe^IV^(O)(L)\]^3+^ (L = TPA\*) (**10**)   1                          --0.03       0.92                             ([@ref61])
  \[(TPA\*)~2~Fe^IV^~2~(μ-O)~2~\]^4+^                            1                          --0.03       2.04                             ([@ref62])
  \[(TPA\*)~2~Fe^III^Fe^IV^(μ-O)~2~\]^3+^ (**6**)                1                          0.11         0.44                             ([@ref62])
  \[(HO)(L)Fe^III^--O--Fe^IV^(O)(L)\]^2+^ (L = TPA\*) (**7**)    2                          0.09         --0.40                           ([@ref24])
  \[(F)(L)Fe^III^--O--Fe^IV^(O)(L)\]^2+^ (L = TPA\*) (**8**)     2                          0.10         0.60                             ([@ref25])
  \[(H~2~O)(L) Fe^III^--O--Fe^IV^(O)(L)\]^3+^ (L = 6Me~3~TPA)    2                          0.10         1.14                             ([@ref38]), ^[@ref39]^
  \[(H~2~O)(L) Fe^III^--O--Fe^IV^(O)(L)\]^3+^ (L = 6MeTPA)       2                          0.08         0.5                              ([@ref40])
  \[Fe^IV^(O)(TPA)(MeCN)\]^2+^                                   1     724                  0.01         0.92             28(2)           ([@ref63])
  \[Fe^IV^(O)(6MeTPA)(MeCN)\]^2+^ (**12**)                       1     770                                                                ([@ref42])
  \[Fe^IV^(O)(QBPA)(MeCN)\]^2+^ (**13**)                         1     770                                                                ([@ref42])
  \[Fe^IV^(O)(TQA)(MeCN)\]^2+^ (**14**)                          2     650, 900             0.24         --1.05           17(1)           ([@ref10])
  \[Fe^IV^(O)(Me~3~NTB)(MeCN)\]^2+^ (**15**)                     1     770                  0.02         1.53             28(7)           ([@ref46])
  Fe^IV^O enzyme intermediates                                                                                                            
  taurine dioxygenase (TauD-***J***)                             2                          0.30         --0.88           10.5            ([@ref3])
  prolyl 4-hydroxylase                                           2                          0.30         --0.82           15.5            ([@ref64])
  halogenase CytC3                                               2                          0.30, 0.22   --1.09, −0.70    8.1             ([@ref52])
  halogenase SyrB2                                               2                          0.30, 0.23   1.09, 0.76                       ([@ref18])
  tyrosine hydroxylase                                           2                          0.25         1.27             12.5            ([@ref65])

Compared to its *S* = 1 counterparts characterized at that time, species **2** was relatively unstable, with a *t*~1/2~ of 30 s at 25 °C. Closer inspection of the self-decay of **2** revealed an intramolecular pathway through which the reactive *S* = 2 oxoiron(IV) center attacked one of the terminal methyl groups of the ligand to form an alkoxoiron(III) product.^[@ref11]^ This result demonstrated that the Fe^IV^=O unit of **2** was reactive enough to cleave a C--H bond with a bond strength of ∼93 kcal mol^--1^ within a few minutes at 25 °C. Indeed, upon perdeuteration of the methyl groups in TMG~3~tren to form *d*~36~-TMG~3~tren, a large KIE of 24 was observed at 25 °C, and the increased stability of the \[Fe^IV^(O)(*d*~36~-TMG~3~tren)\]^2+^ isotopomer allowed its isolation and crystallization to afford the first structure of a synthetic high-spin oxoiron(IV) species ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}).^[@ref11]^ Complex **2** was found to have an Fe^IV^=O distance of 1.661(2) Å and an Fe^IV^=O stretch of 843 cm^--1^. These values were comparable to those reported for structurally characterized *S* = 1 oxoiron(IV) species,^[@ref5]^ consistent with the expectation that the Fe^IV^=O bond order should be independent of the spin state.

The same steric constraints of the TMG~3~tren ligand that enforce the *C*~3~ symmetry are also responsible for the diminished reactivity between **2** and external organic substrates. Steric hindrance by the ligand is best illustrated by the difference in the rates of oxidation of 1,4-cyclohexadiene (CHD) and 9,10-dihydroanthracene (DHA). While these substrates have approximately the same C--H bond dissociation energy (BDE), the oxidation of DHA was 13 times slower than that of CHD,^[@ref15]^ consistent with greater steric hindrance from the approach of the bulkier DHA to the oxo moiety. In contrast, CHD and DHA were oxidized at comparable rates by other oxoiron(IV) species such as \[Fe^IV^(O)(TMC)(MeCN)\]^2+^.^[@ref16]^

In order to provide greater access to the Fe^IV^=O unit, England subsequently converted the tetradentate ligand TMG~3~tren to the facial tridentate ligand TMG~2~dien, in which one of the TMG~3~tren donor arms was replaced with a methyl group.^[@ref17]^ The corresponding oxoiron(IV) species \[Fe^IV^(O)TMG~2~dien(MeCN)\]^2+^ (**3-MeCN**) ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}) retained the *S* = 2 ground state of **2**, with similar Mössbauer parameters of δ = 0.08 mm s^--1^ and Δ*E*~Q~ = 0.58 mm s^--1^ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). However, the reactivity of **3-MeCN** was found to greatly surpass that of **2**, with a 630-fold increase in the DHA oxidation rate. In addition, the MeCN ligand in **3-MeCN** could be replaced by Cl^--^ and N~3~^--^ to form **3-Cl** and **3-N**~**3**~, respectively. Notably, **3-Cl** exhibited an Fe^IV^--Cl bond distance of 2.27 Å as measured by EXAFS, comparable to the Fe^IV^--Cl distance of 2.31 Å found for the SyrB2 intermediate.^[@ref18]^

Using a parallel strategy, Borovik and co-workers reported the structural characterization of a different trigonal-bipyramidal *S* = 2 oxoiron(IV) species, \[Fe^IV^(O)(H~3~buea)\]^1--^ (**4**) ([Figures [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"} and [3](#fig3){ref-type="fig"}).^[@ref12]^ Like TMG~3~tren, H~3~buea is a tripodal N~4~ ligand with bulky end caps, but the equatorial donors are anionic. The negatively charged ligand gave rise to an oxoiron(IV) complex with Mössbauer parameters of δ = 0.02 mm s^--1^ and Δ*E*~Q~ = 0.43 mm s^--1^ ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Complex **4** has an Fe^IV^=O bond length of 1.680(1) Å, slightly longer than that reported for **2** (1.661(2) Å) ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}), and an Fe^IV^=O stretch of 799 cm^--1^ in its IR spectrum, 44 cm^--1^ weaker than that found for the shorter Fe^IV^=O bond of **2**.^[@ref12]^ Perhaps the most interesting feature of the chemistry of **4** is the fact that it was generated by one-electron oxidation of its iron(III) congener \[Fe^III^(O)(H~3~buea)\]^2--^ (**4**~**red**~), which has also been structurally characterized.^[@ref19]^ The H~3~buea ligand was designed to provide a hydrogen-bond donor on each arm of the tripod to interact with the oxo ligand. These interactions were clearly observed for the oxo ligand of **4**~**red**~ but significantly diminished for the oxo ligand in **4**, reflecting the change in the nucleophilicity of the oxo ligand upon oxidation of the iron(III) center to iron(IV) as well as the shift of the iron(IV) center away from the plane of the urea H-bond donors in complex **4**.^[@ref12]^

Similarly, Chang and co-workers utilized a tripodal tris(pyrrolide) ligand scaffold to support another trigonal-bipyramidal *S* = 2 oxoiron(IV) center, \[Fe^IV^(O)(tpa^Ph^)\]^−^ (**5**) ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}),^[@ref20]^ which, like **2**, has a Mössbauer isomer shift of 0.09 mm/s ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Its reactivity with organic substrates reflected a sterically protected oxoiron(IV) center. Although **5** did not react with triphenylphosphine, it did oxidize the less bulky and more easily oxidized dimethylphenylphosphine to the corresponding phosphine oxide. Similarly, the oxoiron(IV) species was capable of oxidizing CHD but not the more bulky DHA.^[@ref20]^

3. Dinuclear Complexes with *S* = 2 Oxoiron(IV) Components {#sec3}
==========================================================

While the trigonal-bipyramidal oxoiron(IV) complexes **2**--**5** did indeed achieve an *S* = 2 ground state, their Mössbauer isomer shifts (∼0.1 mm s^--1^) were notably smaller than those of TauD-***J*** and related enzyme intermediates (∼0.3 mm s^--1^). Moreover, their intermolecular reactivity was limited by the steric constraints on access to the oxo moiety imposed by the ligand. For this reason, our group sought out alternate strategies to obtain *S* = 2 oxoiron(IV) complexes.

In the course of developing models for high-valent diiron intermediates of methane monooxygenase and class 1A ribonucleotide reductases,^[@ref21]−[@ref23]^ postdoctoral associate Genqiang Xue discovered an interesting series of diiron complexes supported by the tetradentate ligand TPA\* ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}). TPA\* is an electron-rich derivative of tris(2-pyridylmethyl)amine (TPA) with electron-donating substituents at the 3-, 4-, and 5-positions of all three pyridines to stabilize a highly reactive terminal oxoiron(IV) center. In this series of (L)Fe--O--Fe^IV^(O)(L) complexes, the left-hand (L)Fe--O fragment can be construed as the sixth ligand of the right-hand Fe^IV^(O)(L) unit. We found that the oxidation state of the left-hand fragment could be used to tune the spin state of the adjacent terminal oxoiron(IV) center, leading to the most reactive oxoiron(IV) complexes to date.

![Generation of terminal *S* = 2 oxoiron(IV) centers in a diiron framework, where each iron center is supported by the electron-rich TPA ligand TPA\*.](ar-2015-00244y_0004){#fig4}

Starting with the *S* = ^3^/~2~ diamond-core complex \[Fe^III^Fe^IV^(μ-O)~2~(TPA\*)~2~\]^3+^ (**6**) ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"}), Xue found that adding hydroxide, fluoride, or methoxide opened up the diamond core to generate *S* = ^1^/~2~ derivatives with antiferromagnetically coupled (*S*~a~ = ^5^/~2~ Fe^III^--X)/(*S*~b~ = 2 Fe^IV^=O) species featuring a high-spin terminal oxoiron(IV) center (**7**, **8**, and **9**, respectively).^[@ref24]−[@ref28]^ In the course of this investigation, we also obtained **10**, the one-electron-oxidized derivative of **7**, which was characterized to have a ferromagnetically coupled (*S*~a~ = 1 Fe^IV^--OH)/(*S*~b~ = 1 Fe^IV^=O) center ([Figure [4](#fig4){ref-type="fig"}](#fig4){ref-type="fig"} and [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). We speculate that the spin states of the terminal oxoiron(IV) units in **7** and **10** differ because of the nature of the adjacent (HO)(TPA\*)Fe--O^--^ unit. The more reduced HO--Fe^III^--O^--^ unit of **7** should be a better π donor than the corresponding HO--Fe^IV^--O^--^ unit in **10**, leading to a decrease in the ligand-field splitting of the Fe^IV^=O unit in **7** that gives rise to its observed *S* = 2 spin state. Complexes **7**--**10** thus constitute a unique set of structurally related complexes supported by the same tetradentate ligand but having a terminal oxoiron(IV) center in either an *S* = 1 or 2 spin state, which affects their HAT abilities.

Because of the thermal instability of **7**--**9**, their HAT reactivities had to be probed at −80 °C with DHA as the substrate ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). Notably, the three diiron complexes containing a terminal *S* = 2 oxoiron(IV) unit, **7**--**9**, demonstrated the highest rates of DHA oxidation.^[@ref24]^ The 10-fold higher reactivity of **8** and **9** is attributed to the absence of the hydrogen bond between the Fe^III^--OH and Fe^IV^=O units in **7**.^[@ref27]^ Complex **7** in turn reacts 3000-fold faster than **10**, which has a terminal *S* = 1 oxoiron(IV) unit. Notably, these two complexes constitute the only pair of complexes in which the oxoiron(IV) units are in nearly identical environments but have different spin states and provide the strongest experimental argument thus far in favor of the higher reactivity of the *S* = 2 oxoiron(IV) unit, as predicted by computational methods.^[@ref29]−[@ref33]^ Complex **10** in turn was 1000-fold more reactive than the diamond-core complex **6**, demonstrating that a terminal oxo unit is better at HAT than a bridging oxo unit. Overall, the series of five diiron complexes **6**--**10** shown in [Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"} represent an impressive 34-million-fold range in HAT reactivity.^[@ref24]^

![Second-order rate constants for the reaction of oxoiron(IV) complexes with 9,10-dihydroanthracene (DHA) at −80 °C. Red and blue bars indicate complexes with *S* = 2 and *S* = 1 oxoiron(IV) centers, respectively. All of the iron centers are supported by the TPA\* ligand except that in **14**, which is supported by the TQA ligand.](ar-2015-00244y_0005){#fig5}

4. Oxoiron(IV) Complexes Supported by Sterically Hindered TPA Ligands {#sec4}
=====================================================================

Despite our success in generating *S* = 2 oxoiron(IV) species supported by electron-rich TPA ligands, these reactive centers were housed within a diiron core, making them less faithful analogues of mononuclear non-heme iron enzyme active sites. Furthermore, the thermal instability of the most reactive complexes required reactivity studies to be carried out only at −80 °C, a temperature too low for substrates with strong C--H bonds to be oxidized. We thus focused on generating an *S* = 2 oxoiron(IV) complex within a mononuclear six-coordinate environment.

One strategy to diminish the energy gap between the d~*xy*~ and d~*x*^2^--*y*^2^~ orbitals within a six-coordinate oxoiron(IV) environment is to weaken the equatorial ligand field and decrease the d~*x*^2^--*y*^2^~ orbital energy. For example, by replacing the relatively strong-field pyridine ligands that support many of synthetic oxoiron(IV) complexes with weaker-field donors, one could in principle attain an *S* = 2 ground state. Indeed, the successful generation of the aqueous oxoiron(IV) complex **1**([@ref8]) serves to demonstrate the viability of this approach, but analogous attempts to employ carboxylate ligands have not yet led to *S* = 2 oxoiron(IV) complexes sufficiently stable to characterize.^[@ref34]−[@ref36]^

We thus applied a modified strategy by modulating the steric environment around the TPA pyridine nitrogen atoms to weaken the ligand field about the iron center. Such an approach was used in the 1990s to tune the spin states of various Fe(TPA) complexes, where the introduction of one or more α-substituents on the pyridine rings of TPA generated a steric interaction between the Fe center and the H atoms of the α-substituent, preventing the formation of the short Fe--N~Py~ bonds necessary to adopt lower-spin configurations.^[@ref37]^ The steric effect of α-methyl substitution on the pyridine rings is clearly illustrated in the ^1^H NMR spectra of two \[Fe^II^(L)(MeCN)~2~\](ClO~4~) complexes. The spectrum of the L = TPA complex is consistent with a diamagnetic low-spin *S* = 0 species ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}, top), while that of the L = 6Me~3~TPA complex instead reveals a paramagnetic high-spin *S* = 2 species ([Figure [6](#fig6){ref-type="fig"}](#fig6){ref-type="fig"}, bottom). In fact, it was found that only a single methyl α-substituent was sufficient to trigger a spin-state change in this (TPA)Fe^II^ family of compounds ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).^[@ref37]^

![^1^H NMR spectra of (top) *S* = 0 \[Fe^II^(TPA)(MeCN)~2~\](ClO~4~)~2~ and (bottom) *S* = 2 \[Fe^II^(6Me~3~TPA)(MeCN)~2~\](ClO~4~)~2~ in CD~3~CN. Reproduced from ref ([@ref37]). Copyright 1997 American Chemical Society.](ar-2015-00244y_0006){#fig6}

###### Spin States of Complexes Supported by TPA Ligands versus the Number of α-Substituents (*N*~sub~) on the Pyridine Rings

                              *N*α-~sub~ = 0           *N*α-~sub~ = 1           *N*α-~sub~ = 3           ref(s)
  --------------------------- ------------------------ ------------------------ ------------------------ ------------------------------------
  (L)Fe^II^(MeCN)~2~          0                        0                        2                        ([@ref37])
  (L)Fe^III^(OOR)             ^1^/~2~                  ^1^/~2~ and ^5^/~2~      ^5^/~2~                  ([@ref37])
  (L)Fe^III^(O)~2~Fe^IV^(L)   ^3^/~2~ \[^1^/~2~, 1\]   ^1^/~2~ \[^5^/~2~, 2\]   ^1^/~2~ \[^5^/~2~, 2\]   ([@ref38]−[@ref41])
  (L)Fe^IV^(O)(MeCN)          1                        1                        2                        ([@ref10]), ^[@ref42]^, ^[@ref57]^

The same strategies to enforce spin-state changes within stable Fe^II^ coordination complexes extended to reactive Fe^III^--peroxo intermediates as well. The alkylperoxoiron(III) intermediates \[Fe^III^(TPA)(OH~2~)(OO^*t*^Bu)\]^+^ and \[Fe^III^(6Me~3~TPA)(OH~2~)(OO^*t*^Bu)\]^+^ were distinguished in having an *S* = ^1^/~2~ Fe^III^ center for the former and an *S* = ^5^/~2~ Fe^III^ center for the latter. Interestingly, the complex with one α-substituent, \[Fe^III^(6MeTPA)(OH~2~)(OO^*t*^Bu)\]^+^, consisted of a mixture of low-spin Fe^III^ and high-spin Fe^III^ centers, hinting at the flexibility of this synthetic strategy to provide access to intermediate points prior to a complete spin-state change ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}).^[@ref37]^

Gratifyingly, this same synthetic strategy could be extended to oxodiiron(III/IV) systems. In 1995, an \[Fe^III^Fe^IV^(μ-O)~2~(TPA)~2~\]^3+^ diamond-core complex was identified and described as having valence-delocalized (*S*~a~ = ^1^/~2~ Fe^III^)/(*S*~b~ = 1 Fe^IV^) centers with a system spin of *S* = ^3^/~2~.^[@ref38],[@ref39]^ The corresponding complexes with 6MeTPA or 6Me~3~TPA instead gave rise to valence-localized (*S*~a~ = ^5^/~2~ Fe^III^)/(*S*~b~ = 2 Fe^IV^) centers with a system spin of *S* = ^1^/~2~ as a result of antiferromagnetic coupling of the two iron components.^[@ref40],[@ref41]^ Thus, the introduction of even one α-substituent was sufficient to trigger a change in the spin states of both Fe centers from low-spin to high-spin ([Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}). Further characterization of \[Fe^III^Fe^IV^(O)~2~(6Me~3~TPA)~2~\]^3+^ by resonance Raman spectroscopy revealed an Fe^IV^=O vibration at 840 cm^--1^,^[@ref41]^ a frequency similar to those associated with \[Fe^IV^(O)(TMC)(MeCN)\]^2+^ (*S* = 1) and **2** (*S* = 2), suggesting that the *S* = 2 Fe^IV^ unit was in fact a terminal oxoiron(IV) center.^[@ref15],[@ref35]^ The diiron(III/IV) complexes of 6MeTPA and 6Me~3~TPA showed for the first time that synthetic *S* = 2 oxoiron(IV) centers could be obtained, albeit within a diiron framework. While the reactivity of these complexes has not been investigated, they are closely related to the *S* = ^1^/~2~ diiron complexes supported by the electron-rich TPA\* ligand discussed in the preceding section, **7**--**9**, for which very high rates of oxidation of DHA have been reported ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}).

With evidence that this synthetic strategy could stabilize a terminal *S* = 2 oxoiron(IV) center in a diiron framework, our group attempted to apply these ideas to the generation of mononuclear *S* = 2 oxoiron(IV) species by modifying the parent *S* = 1 \[Fe^IV^(O)(TPA)(MeCN)\]^2+^ complex ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}). In 2006, we reported the characterization of oxoiron(IV) complexes of 6MeTPA and QBPA (**12** and **13**, respectively; [Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}) that were obtained by reactions of peracetic acid with their iron(II) precursors.^[@ref42]^ The new species **12** and **13** exhibited respective near-IR absorption features of λ~max~ = 770 and 775 nm, which were red-shifted compared with that of \[Fe^IV^(O)(TPA)(MeCN)\]^2+^ (λ~max~ = 720 nm), indicating a weakening of the ligand field (Δν ∼ 900 cm^--1^) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Importantly, these results indicated that the steric effect of a hydrogen atom on an sp^3^-hybridized α-carbon substituent (6MeTPA) was comparable to that on an sp^2^-hybridized α-carbon substituent (QBPA).^[@ref42]^ However, in neither case did the ground spin state of the oxoiron(IV) center deviate from *S* = 1. Although DFT calculations by Ghosh predicted that a TPA ligand with three α-substituents ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}) should lead to an *S* = 2 oxoiron(IV) center,^[@ref43]^ attempts at that time to obtain oxoiron(IV) complexes of such ligands were not successful, suggesting that the right reaction conditions had not yet been found to stabilize species that are likely to be more reactive than the *S* = 1 complexes **12** and **13**.

![Synthetic oxoiron(IV) complexes supported by TPA and derivatives. The asterisk indicates a complex with an *S* = 2 ground state.](ar-2015-00244y_0007){#fig7}

![TPA ligand and derivatives with α-substituents.](ar-2015-00244y_0008){#fig8}

Three years later, we discovered the utility of 2-(*tert*-butylsulfonyl)iodosylbenzene (ArIO)^[@ref44]^ as an oxidant to synthesize the *S* = 2 oxoiron(IV) complex **2**.^[@ref15]^ We ascribe our success in synthesizing **2** by this method to the efficiency of O-atom transfer from ArIO to the iron(II) precursor and the steric barriers that minimized comproportionation of the Fe^IV^(O) product with residual precursor. This strategy was subsequently applied by postdoctoral associate Achintesh Biswas for the successful generation of the oxoiron(IV) complex supported by the TQA ligand ([Figure [8](#fig8){ref-type="fig"}](#fig8){ref-type="fig"}).^[@ref10]^

We reported the synthesis of \[Fe^IV^(O)(TQA)(MeCN)\]^2+^ (**14**) ([Figure [7](#fig7){ref-type="fig"}](#fig7){ref-type="fig"}) at −40 °C earlier this year^[@ref10]^ and found it to have a *t*~1/2~ of only 15 min at −40 °C. Mössbauer studies established it as an *S* = 2 oxoiron(IV) complex with an isomer shift of 0.24 mm s^--1^, which makes it the only synthetic high-spin oxoiron(IV) complex to have an isomer shift that falls within the range of values found for enzymatic oxoiron(IV) intermediates (0.22--0.30 mm s^--1^; [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). Furthermore, among synthetic oxoiron(IV) complexes characterized to date, the magnetic hyperfine parameters deduced for **14** from the analysis of high-field Mössbauer data^[@ref10]^ most closely resemble those found for TauD-***J***^[@ref3]^ and the corresponding intermediate for prolyl-4-hydroxylase,^[@ref64]^ making **14** the closest electronic model for these high-spin oxoiron(IV) enzyme intermediates to date.

This resemblance leads us to ask why **14**, of all the synthetic oxoiron(IV) complexes characterized, should have an isomer shift most similar to those of the enzyme intermediates, given that its donor set does not match the 2-His-2-carboxylate combination associated with TauD-***J**.* All other *S* = 2 oxoiron(IV) complexes with N-donor sets listed in [Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"} have isomer shifts of 0.12 mm s^--1^ or smaller, while that of \[Fe^IV^(O)(OH~2~)~5~\]^2+^ (**1**)^[@ref8],[@ref10]^ at 0.38 mm s^--1^ is above the range for enzyme intermediates. As the isomer shift reflects the donation of electron density from the ligands into the iron 4s orbital, TQA must represent a good electronic approximation of the donor set found in the enzyme active sites. Indeed, DFT calculations predict **14** to have the experimentally observed isomer shift of 0.24 mm s^--1^.^[@ref10]^ Additional examples of *S* = 2 oxoiron(IV) complexes with isomer shifts falling into this range would obviously help to clarify the factors that govern the isomer shifts, and hence the electronic environments, of oxoiron(IV) enzyme intermediates.

Complex **14** also appears to be a good functional model for TauD-***J***. Its thermal instability translates into high intermolecular HAT reactivity. Complex **14** exhibits the highest rates of substrate oxidation by a synthetic oxoiron(IV) complex in an organic solvent and cleaves the strong C--H bonds of cyclohexane (BDE ≈ 99 kcal/mol) with a rate constant (*k*~2~) of 0.37 M^--1^ s^--1^ at −40 °C. For comparison, its *S* = 1 analogue \[Fe^IV^(O)(TPA)(MeCN)\]^2+^ is not able to oxidize cyclohexane at all at −40 °C, suggesting that the simple substitution of pyridine rings with quinoline rings not only changes the spin state but also dramatically enhances the reactivity profile.^[@ref10]^ In fact, after temperature adjustment, the rate of cyclohexane oxidation by **14** approaches that for the oxidation of taurine by TauD-***J*** at 5 °C.^[@ref45]^

To be able to place the HAT reactivity of **14** and those of the dinuclear *S* = 2 oxoiron(IV) complexes **7**--**9** within a common framework, we measured the DHA oxidation rate of **14** at −80 °C and obtained a *k*~2~ value of 200 M^--1^ s^--1^ ([Figure [9](#fig9){ref-type="fig"}](#fig9){ref-type="fig"}). This comparison shows that **14** is almost as reactive with DHA as **8** and **9** ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). This is an important point, as it suggests that the high reactivity of these species is independent of whether the *S* = 2 Fe^IV^(O) unit is in a mononuclear or a dinuclear framework. These results further support our idea that the (X)(TPA\*)Fe^III^--O^--^ unit in these dinuclear systems can be construed simply as a sixth ligand for the *S* = 2 oxoiron(IV) center.

![Plot of the pseudo-first-order rate constant *k*~obs~ vs DHA concentration for the reaction of **14** (1.0 mM) with DHA in a 3:1 acetone-*d*~6~/acetonitrile-*d*~3~ mixture at −80 °C.](ar-2015-00244y_0009){#fig9}

[Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"} allows us to establish a relationship between spin state and HAT reactivity for oxoiron(IV) centers supported by TPA-based ligands, where *S* = 2 oxoiron(IV) centers appear to be more reactive than *S* = 1 oxoiron(IV) centers. However, replacing the three quinoline donors of TQA with *N*-methylbenzimidazole donors in Me~3~NTB gives the *S* = 1 complex \[Fe^IV^(O)(Me~3~NTB)(MeCN)\]^2+^ (**15**) ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), which exhibits HAT reactivity comparable to that of **14** despite having a different ground spin state.^[@ref10],[@ref46]^ This apparent paradox is illustrated by the plot of log *k*~2~^′^ versus C--H bond dissociation energy in [Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}, where the HAT oxidation rates measured for the two complexes fall on the same line. Thus, an *S* = 1 oxoiron(IV) complex can be just as reactive as an *S* = 2 oxoiron(IV) complex. It is hypothesized that the high reactivity of **15** may arise from a low-lying *S* = 2 excited state, but additional experimental data would be helpful to shed further light on this puzzling comparison.

![Plot of log *k*~2~^′^ vs C--H bond dissociation energy for the reactions of hydrocarbons with **14** (red) and **15** (blue) at −40 °C in CH~3~CN. The *k*~2~^′^ values are second-order rate constants normalized by the number of equivalent substrate C--H bonds that can be attacked. Reproduced from ref ([@ref10]). Copyright 2015 American Chemical Society.](ar-2015-00244y_0010){#fig10}

5. Challenges {#sec5}
=============

Through the use of different synthetic strategies, we and others have generated *S* = 2 oxoiron(IV) complexes in both trigonal-bipyramidal and pseudo-octahedral geometries to shed light on why such centers are used to effect HAT in enzymes like TauD. In this Account, we have focused on the role of the spin state and provided experimental evidence that the *S* = 2 ground state can lead to enhanced HAT reactivity relative to *S* = 1 oxoiron(IV) complexes supported by similar ligand scaffolds ([Figure [5](#fig5){ref-type="fig"}](#fig5){ref-type="fig"}). However, as exemplified by the reactivity of the *S* = 1 complex **15** ([Figure [10](#fig10){ref-type="fig"}](#fig10){ref-type="fig"}), this correlation does not strictly hold, and further investigation of the factors that control the reactivity is required. In particular, Mayer has argued that the HAT reactivity of an oxoiron(IV) complex is related to the strength of the O--H bond formed in the reaction, which in turn depends on the Fe^IV/III^ potential and the p*K*~a~ of the Fe^III^--OH moiety,^[@ref47]^ but these properties have proven difficult to measure. Indeed, only Borovik has thus far been able to determine such thermodynamic properties for an oxoiron(IV) complex.^[@ref48]^

Among other challenges are the trapping and characterization of the proposed *S* = 2 oxoiron(IV) intermediate generated upon reaction of O~2~ with \[Fe^II^(Tp^Ph2^)(Y)\] (Tp^Ph2^ = hydridotris(3,5-diphenylpyrazolyl)borate; Y = PhC(O)CO~2~^--^ or Ph~2~C(OH)CO~2~^--^), which respectively are functional models for non-heme iron enzymes that use 2-oxo- or 2-hydroxoacids as electron sources for O~2~ activation.^[@ref49],[@ref50]^ This putative oxidant is responsible for the observed hydroxylation of a phenyl ring of the Tp^Ph2^ supporting ligand. Moreover, it can also effect intermolecular oxidation of cyclohexane and *n*-butane in competition with the intramolecular ligand hydroxylation.^[@ref16]^

A different synthetic challenge is to mimic the reactivity of the non-heme iron halogenases CytC3 and SyrB2, which convert substrate C--H bonds into C--X (X = Cl, Br) bonds via an *S* = 2 Fe^IV^(O)(X) intermediate.^[@ref51],[@ref52]^ Modeling of these enzymes requires the generation of *S* = 2 oxoiron(IV) complexes with halide ligands coordinated *cis* to the oxo moiety and the demonstration of halide transfer to a C--H bond. This is a research direction that is clearly of interest to us^[@ref17]^ and to the groups of Comba^[@ref53]^ and Costas.^[@ref54]^

Finally, *S* = 2 oxoiron(IV) complexes with oxygen-rich ligand environments related to \[Fe^IV^(O)(OH~2~)~5~\]^2+^ (**1**) would be welcome additions to this family. There are two intriguing recent developments relevant to this Account. Nocera and co-workers employed sterically bulky alkoxide ligands to make a trigonal Fe^II^(OR)~3~^--^ complex. When reacted with PhIO or Me~3~NO, this complex forms a highly reactive species that is proposed by DFT to have a pseudotetrahedral *S* = 2 oxoiron(IV) center.^[@ref55]^ In a different approach, Long and co-workers exploited the weak-field carboxylate donors that support iron(II) centers in a metal--organic framework to generate a reactive iron-based intermediate upon reaction with N~2~O that is capable of oxidizing ethane to ethanol.^[@ref56]^ While no direct spectroscopic information is currently available, computational studies suggest that this intermediate is a pseudo-octahedral *S* = 2 oxoiron(IV) species.^[@ref57],[@ref58]^ Clearly, these creative synthetic strategies will unveil even more interesting chemistry related to *S* = 2 oxoiron(IV) complexes in the future.
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